Novo Nordisk enters USD 6.3m legal settlement in US
Allegations that Novo Nordisk had breached the US Trade Agreement Act of 1979 have been resolved in a settlement, though the Danish pharmaceutical company admits no wrongdoing.
by ritzau, translated by daniel pedersen
Novo Nordisk has entered a settlement in the US, paying USD 6.3m according to MarketWire.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk to start human trial of new diabetes drug
For subscribers
Lundbeck sued in the US – again
For subscribers
